The National Health Commission, the State Administration of Traditional Chinese Medicine, and the National Center for Disease Control and Prevention issued the "Notice on Further Strengthening the Management of the Use of Electronic Medical Records in Medical Institutions"
source:National Health Commission, June 30, 2025
It is proposed to strengthen internal management within medical institutions and incorporate the standardized use and management of electronic medical records into performance evaluations. Standardize the use of electronic medical records to ensure full process traceability, employing technologies such as digital watermarking to ensure traceability of the entire process. Ensure data security, establish an electronic medical record information security protection system, and mitigate potential security risks. Strengthen oversight by health administrative departments, and include the standardized use of electronic medical records by medical institutions as a key assessment basis for hospital reviews, hospital inspections, and smart hospital development.
Interpretation:
· Strengthen the internal management of medical institutions: First, the scope of electronic medical records is clarified, including outpatient (emergency) medical records and inpatient medical records; second, the main responsibility of medical institutions is strengthened. Medical institutions bear the main responsibility for the use and management of electronic medical record information in their units. They must strictly protect patient privacy in accordance with laws and regulations and must not disclose patients' medical records for non-medical, teaching, and research purposes; third, the management system of medical institutions is improved. Medical institutions should improve the hierarchical management system of electronic medical record information systems, establish a long-term supervision mechanism for the use of electronic medical record information, and establish and improve the handling process of electronic medical record information leakage scenarios; fourth, the requirements for hierarchical management are implemented. Medical institutions should strictly implement hierarchical and classified access control and authority management based on the importance, sensitivity level, usage scenarios, and other specific circumstances of electronic medical record information.
Standardize the use of electronic medical record information:First, standardize the use rights and behaviors of relevant personnel. Medical institutions should provide electronic medical record system operators with proprietary identification and recognition methods, and set corresponding permissions to ensure data security. Second, ensure the traceability of the entire process. Medical institutions must ensure that information such as the operation traces, operation time, and operator of the electronic medical record system can be searched and traced. Support the use of technical means such as digital watermarks to ensure that the use process leaves traces. Third, ensure data security, establish an electronic medical record information security protection system, and make full use of information technology to monitor the use of electronic medical record information.
National Healthcare Security Administration and National Health Commission: Several Measures to Support the High-Quality Development of Innovative Drugs
source:Central People's Government, July 1, 2025
The document proposes 16 measures from five aspects: increasing support for the research and development of innovative drugs, supporting the inclusion of innovative drugs in the basic medical insurance drug list and the commercial health insurance innovative drug list, supporting the clinical application of innovative drugs, improving the diversified payment capacity of innovative drugs, and strengthening guarantee measures.
Interpretation:
Support the use of medical insurance data in innovative drug research and development.Strengthen information exchange and collaboration among medical care, medical insurance, and pharmaceuticals, effectively manage medical insurance data resources, and promote the utilization of public data resources in the medical insurance sector. While ensuring data security and legal and regulatory compliance, explore providing necessary medical insurance data services for innovative drug research and development. Relying on a unified national medical insurance information platform, effectively collect and analyze data on disease spectrum and clinical drug demand, and develop data products tailored to the needs of innovative drug research and development.
Construction and application of medical insurance drug cloud platformProvide medical institutions and patients with services such as rapid response to drug needs and convenient information query. The medical insurance department will provide cooperative support in data sharing, settlement and clearing for eligible commercial health insurance companies. Fully implement the medical insurance supervision and application of drug traceability codes, strengthen the supervision of the entire prescription circulation process, and include the payment of innovative drugs in the key areas of fund supervision.
The Ministry of Finance and the National Health Commission of the People's Republic of China issued a notice announcing the results of the competitive review of the 2025 Central Government Finance Support Demonstration Project for the Reform and High-Quality Development of Public Hospitals.
source:National Ministry of Finance, July 8, 2025
On July 8, the Social Security Department of the Ministry of Finance and the System Reform Department of the National Health Commission jointly issued the "Announcement of the Competitive Review Results of the 2025 Central Government Finance Support for Public Hospital Reform and High-Quality Development Demonstration Project", and planned to identify 20 demonstration project cities.
Interpretation:
· List of cities to be supported:Xicheng District of Beijing, Handan City of Hebei Province, Changzhi City of Shanxi Province, Tongliao City of Inner Mongolia Autonomous Region, Anshan City of Liaoning Province, Nanjing City of Jiangsu Province, Jiaxing City of Zhejiang Province, Fuyang City of Anhui Province, Xiamen City of Fujian Province, Jining City of Shandong Province, Luoyang City of Henan Province, Xiangyang City of Hubei Province, Changsha City of Hunan Province, Foshan City of Guangdong Province, Wuzhou City of Guangxi Zhuang Autonomous Region, Fuling District of Chongqing City, Panzhihua City of Sichuan Province, Nagqu City of Tibet Autonomous Region, and Changji Hui Autonomous Prefecture of Xinjiang Uygur Autonomous Region.
Guangdong Provincial Health Commission: Announced 289 "Artificial Intelligence + Healthcare" application scenario cases
source:Guangdong Provincial Health Commission, July 7, 2025
On July 7, the Guangdong Provincial Health Commission announced the first batch of "artificial intelligence + medical and health" application scenario cases, totaling 289 cases, covering four areas including medical service management, grassroots public health services, health industry development, and medical teaching. "Artificial intelligence +" medical services, pharmaceutical services, medical insurance services, traditional Chinese medicine management services, hospital management, health management services, public health services, medical robots, drug research and development, traditional Chinese medicine industry, medical teaching, medical research and other 12 aspects, a total of 44 application scenarios.
